Quality of life [ Time Frame: overall ] [ Designated as safety issue: No ]

Estimated Enrollment:

100

Study Start Date:

October 2007

Estimated Study Completion Date:

October 2013

Estimated Primary Completion Date:

October 2013 (Final data collection date for primary outcome measure)

Intervention Details:

Radiation: First-Line Bevacizumab and Chemotherapy

Chemotherapy

Drug: Bevacizumab

Chemotherapy

Eligibility

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

Patients with metastatic cancer of colon or rectum

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00537901